Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 11 studies | 29% ± 9% | |
epithelial cell | 10 studies | 41% ± 15% | |
basal cell | 8 studies | 34% ± 19% | |
ciliated cell | 8 studies | 35% ± 14% | |
oligodendrocyte | 8 studies | 27% ± 8% | |
endothelial cell | 6 studies | 24% ± 6% | |
fibroblast | 5 studies | 21% ± 6% | |
club cell | 5 studies | 25% ± 9% | |
goblet cell | 5 studies | 24% ± 10% | |
respiratory goblet cell | 4 studies | 24% ± 10% | |
squamous epithelial cell | 4 studies | 59% ± 20% | |
glutamatergic neuron | 4 studies | 44% ± 23% | |
pericyte | 4 studies | 18% ± 2% | |
smooth muscle cell | 4 studies | 17% ± 1% | |
secretory cell | 4 studies | 33% ± 17% | |
GABAergic neuron | 4 studies | 39% ± 19% | |
oligodendrocyte precursor cell | 4 studies | 24% ± 3% | |
neuron | 3 studies | 30% ± 12% | |
retinal bipolar neuron | 3 studies | 18% ± 3% | |
retina horizontal cell | 3 studies | 26% ± 7% | |
enterocyte | 3 studies | 17% ± 2% | |
type II pneumocyte | 3 studies | 26% ± 13% | |
astrocyte | 3 studies | 25% ± 5% | |
keratinocyte | 3 studies | 28% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 3892.80 | 170 / 170 | 100% | 163.10 | 459 / 459 |
brain | 100% | 5002.85 | 2639 / 2642 | 100% | 85.78 | 705 / 705 |
skin | 100% | 8559.88 | 1809 / 1809 | 100% | 127.89 | 471 / 472 |
thymus | 100% | 4405.02 | 652 / 653 | 100% | 102.16 | 604 / 605 |
esophagus | 100% | 11354.33 | 1445 / 1445 | 99% | 115.76 | 182 / 183 |
ovary | 99% | 2418.83 | 179 / 180 | 100% | 155.35 | 430 / 430 |
intestine | 100% | 6424.54 | 966 / 966 | 99% | 133.11 | 524 / 527 |
prostate | 100% | 4746.79 | 245 / 245 | 99% | 70.92 | 497 / 502 |
stomach | 100% | 4582.80 | 359 / 359 | 99% | 105.91 | 283 / 286 |
adrenal gland | 100% | 3782.22 | 258 / 258 | 99% | 59.75 | 227 / 230 |
lung | 100% | 5953.26 | 577 / 578 | 99% | 104.30 | 1141 / 1155 |
bladder | 100% | 5429.33 | 21 / 21 | 98% | 159.68 | 496 / 504 |
breast | 100% | 4069.76 | 459 / 459 | 98% | 86.80 | 1100 / 1118 |
kidney | 100% | 5271.54 | 89 / 89 | 98% | 55.75 | 880 / 901 |
liver | 99% | 2233.83 | 224 / 226 | 95% | 57.29 | 384 / 406 |
pancreas | 93% | 1756.68 | 304 / 328 | 99% | 135.74 | 176 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 84.56 | 80 / 80 |
spleen | 100% | 2683.58 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 154.41 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 222.07 | 1 / 1 |
adipose | 100% | 3710.14 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3902.50 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 2861.04 | 797 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2872.30 | 833 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 31.01 | 26 / 29 |
peripheral blood | 25% | 349.31 | 228 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030511 | Biological process | positive regulation of transforming growth factor beta receptor signaling pathway |
GO_0032435 | Biological process | negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0098761 | Biological process | cellular response to interleukin-7 |
GO_0006605 | Biological process | protein targeting |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0043542 | Biological process | endothelial cell migration |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0099171 | Biological process | presynaptic modulation of chemical synaptic transmission |
GO_0048023 | Biological process | positive regulation of melanin biosynthetic process |
GO_0032467 | Biological process | positive regulation of cytokinesis |
GO_0031647 | Biological process | regulation of protein stability |
GO_0014047 | Biological process | glutamate secretion |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0043197 | Cellular component | dendritic spine |
GO_0012506 | Cellular component | vesicle membrane |
GO_0016020 | Cellular component | membrane |
GO_0043198 | Cellular component | dendritic shaft |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0005737 | Cellular component | cytoplasm |
GO_0045296 | Molecular function | cadherin binding |
GO_0017022 | Molecular function | myosin binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | GIPC1 |
Protein name | PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) (Tax interaction protein 2) (TIP-2) GIPC PDZ domain containing family member 1 |
Synonyms | RGS19IP1 C19orf3 GIPC |
Description | FUNCTION: May be involved in G protein-linked signaling. |
Accessions | ENST00000393033.9 [O14908-1] K7EJ33 ENST00000589631.5 ENST00000586027.5 [O14908-1] ENST00000591349.5 [O14908-2] ENST00000591245.1 O14908 ENST00000393028.5 [O14908-2] K7ELJ2 ENST00000587934.1 K7ESN1 ENST00000587210.1 K7EM11 K7EIT0 ENST00000345425.6 [O14908-1] ENST00000587969.1 ENST00000589497.5 |